OneSource supports second generic semaglutide approval in Canada
OneSource Specialty Pharma, a leading specialty pharmaceutical CDMO, announced that its partner Orbicular, along with its Canadian…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
OneSource Specialty Pharma
OneSource Specialty Pharma secures SFDA approval for generic semaglutide in Saudi Arabia
Exclusive partnership with Hikma Pharmaceuticals to commercialise product across MENA region
OneSource specialty pharma secures ANVISA GMP certification for Bengaluru unit 2 facility
Approval enables OneSource to supply drug-device combinations including GLP-1s to Brazil, ahead of Semaglutide generics entering…
OneSource Specialty Pharma appoints three new independent directors
The new directors bring leadership experience and expertise in pharma, business strategy, transformation, and M&As among…
OneSource gains EIR with VAI classification from USFDA for its BLD Facility
The report follows an inspection of the facility, conducted from November 14 to November 22, 2024
Onesource Specialty Pharma completes fundraising of $ 95 mn
The fundraising was led by HBM Healthcare Investments
OneSource receives equity commitments of Rs 8,010 Mn at a pre-money equity valuation of $ 1.65 Bn
OneSource is in the process of seeking final approval for the Scheme from NCLT, Mumbai Bench, to thereafter achieve the listing of…
OneSource pharma launches new brand identity at CPHI, Milan
OneSource Pharma targets biologics and drug-device markets with end-to-end solutions and global expansion
OneSource Specialty Pharma enters into strategic licensing agreement with Bhami’s Research…
Partnership grants access to BRL’s HILOPRO technology, enhancing subcutaneous delivery of high-concentration biologic therapies…